CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors

Although the postoperative recurrence rate for pancreatic neuroendocrine tumors (PNETs) is reported to be 13.5%‐30%, the paucity of valuable biomarkers to predict recurrence poses a problem for the early detection of relapse. Hence, this study aimed to identify new biomarkers to predict the recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Miki, Masami, Oono, Takamasa, Fujimori, Nao, Takaoka, Takehiro, Kawabe, Ken, Miyasaka, Yoshihiro, Ohtsuka, Takao, Saito, Daisuke, Nakamura, Masafumi, Ohkawa, Yasuyuki, Oda, Yoshinao, Suyama, Mikita, Ito, Tetsuhide, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639196/
https://www.ncbi.nlm.nih.gov/pubmed/31129920
http://dx.doi.org/10.1002/cam4.2232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639196/
https://www.ncbi.nlm.nih.gov/pubmed/31129920
http://dx.doi.org/10.1002/cam4.2232

Ejemplares similares